Fri, May 7, 2021

Swayampakula Ramakanth Maintained (BCYC) at Strong Buy with Increased Target to $39 on, May 7th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-39-on-may-7th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Increased Target from $31 to $39 on, May 7th, 2021.

Swayampakula has made no other calls on BCYC in the last 4 months.



There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Reni Benjamin of "JMP Securities" Initiated at Buy and Held Target at $53 on, Tuesday, April 20th, 2021